Eastland Medical Systems Ltd

Eastland Medical Systems Ltd (ASX: EMS) remains on track with the development of its anti-malaria treatment ArTiMistTM and will commence a multi dose Phase 1 clinical trial for ArTiMistTM in February, after its Pharmaceutical Division receiving approval from the South African MCC Regulatory Body.

Eastland Medical Systems (ASX EMS) is looking to significantly increase revenues in 2008 as a result of its decision to concentrate on the development of its Pharmaceutical Division - with fast-track low-risk pharmaceutical development and early market entry of pharmaceutical product.

EASTLAND MEDICAL SYSTEMS LTD (ASX: EMS) - Cutting edge of medical technology - Mr Don O'Sullivan, CEO; Boardroomradio is pleased to announce that EASTLAND MEDICAL SYSTEMS LTD (ASX: EMS) has published an audio file.

Eastland Medical Systems Ltd this week commenced production of the new and unique Safe Veterinary Device "VetLok".

Eastland Medical Systems Ltd (Eastland) is pleased to announce the completion of their newly designed tooling for the production of their speciality safety syringe Retralok.

Eastland Medical Systems (ASX: EMS) is now nearing completion of commercial tooling for production of its ClipOn "Safe" needle device. Production is scheduled to commence in mid February 2006 at Eastland's Portland facility in Victoria and shipments for hospital trials in Australia, South Africa and the United Kingdom will follow shortly thereafter.